207 institutions reported holding $1.58B of UROGEN PHARMA LTD (URGN) in SEC 13F filings for 2026-06-30. Largest institutional holders: RTW INVESTMENTS, LP ($167.2M), BlackRock, Inc. ($117.8M), MORGAN STANLEY ($94.8M), Kynam Capital Management, LP ($89.6M), Jefferies Financial Group Inc. ($80.9M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30